Suppr超能文献

独活寄生汤治疗寒湿痹阻型膝骨关节炎的疗效:汇总分析。

Efficacy of Duhuo Jisheng Decoction for Treating Cold-Dampness Obstruction Syndrome-Type Knee Osteoarthritis: A Pooled Analysis.

机构信息

The Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.

The Research Team on Bone and Joint Degeneration and Injury of Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510120, China.

出版信息

Biomed Res Int. 2022 Jun 21;2022:2350404. doi: 10.1155/2022/2350404. eCollection 2022.

Abstract

AIM

The aim of this study is to provide evidence of the effect of Duhuo Jisheng decoction (DHJSD) on knee osteoarthritis (KOA) of the cold-dampness obstruction syndrome type.

METHODS

We searched PubMed, Embase, the Cochrane Library, the China National Knowledge Infrastructure, the Wanfang database, and the China Biology Medicine for randomized controlled trials (RCTs) evaluating DHJSD or DHJSD combined with other conventional therapies (DHJSD group) compared to conventional therapy (control group) for cold-dampness obstruction syndrome-type KOA. We calculated the pooled odds ratio (OR), mean difference (MD), and 95% confidence interval (CI) using fixed- or random-effects models.

RESULTS

Eleven RCTs, with a total of 895 patients, were included. The results showed that DHJSD could significantly improve the effective rate (OR = 3.13, 95%CI = 2.07 to 4.72, < 0.001), reduce both the WOMAC (MD = -12.06, 95%CI = -16.34 to -7.79, < 0.001) and VAS (MD = -1.02, 95%CI = -1.54 to -0.50, = 0.0001) scores, and reduce the serum IL-6 (MD = -0.80, 95%CI = -0.90 to -0.69, < 0.001) and TNF- (MD = -2.49, 95%CI = -2.77 to -2.21, < 0.001) levels during the treatment of cold-dampness obstruction syndrome-type KOA. The subgroup analysis showed that compared with glucosamine sulfate (GS) alone, DHJSD combined with GS significantly improved the effective rate (OR = 2.59, 95%CI = 1.19 to 5.65, = 0.02) and reduced the WOMAC (MD = -13.83, 95%CI = -16.14 to -11.51, < 0.001) and VAS (MD = -0.91, 95%CI = -1.27 to -0.55, < 0.001) scores. DHJSD + warm-needle acupuncture (WA) lowered the VAS score more than WA alone. There was no significant difference in the decrease in serum IL-1 between the DHJSD and control groups.

CONCLUSION

This study shows that DHJSD can improve the clinical efficacy and reduce the VAS and WOMAC scores in the treatment of cold-dampness obstruction syndrome-type KOA. Compared with GS or WA alone, the combined application of DHJSD with GS or WA could better reduce both the VAS and WOMAC scores.

摘要

目的

本研究旨在提供独活寄生汤治疗寒湿气滞型膝骨关节炎(KOA)的疗效证据。

方法

我们检索了 PubMed、Embase、Cochrane 图书馆、中国知网、万方数据库和中国生物医学文献数据库,以评估独活寄生汤(DHJSD)或独活寄生汤联合其他常规疗法(DHJSD 组)与常规疗法(对照组)治疗寒湿气滞型 KOA 的随机对照试验(RCT)。我们使用固定或随机效应模型计算了汇总优势比(OR)、均数差(MD)和 95%置信区间(CI)。

结果

纳入了 11 项 RCT,共计 895 例患者。结果表明,独活寄生汤可显著提高有效率(OR=3.13,95%CI=2.07 至 4.72,<0.001),降低 WOMAC(MD=-12.06,95%CI=-16.34 至-7.79,<0.001)和 VAS(MD=-1.02,95%CI=-1.54 至-0.50,=0.0001)评分,降低血清 IL-6(MD=-0.80,95%CI=-0.90 至-0.69,<0.001)和 TNF-(MD=-2.49,95%CI=-2.77 至-2.21,<0.001)水平。亚组分析显示,与单独使用硫酸氨基葡萄糖(GS)相比,独活寄生汤联合 GS 显著提高了有效率(OR=2.59,95%CI=1.19 至 5.65,=0.02),降低了 WOMAC(MD=-13.83,95%CI=-16.14 至-11.51,<0.001)和 VAS(MD=-0.91,95%CI=-1.27 至-0.55,<0.001)评分。独活寄生汤+温针灸(WA)组 VAS 评分下降优于 WA 组单独治疗。DHJSD 组与对照组之间血清 IL-1 的降低无显著差异。

结论

本研究表明,独活寄生汤可提高寒湿气滞型 KOA 的临床疗效,降低 VAS 和 WOMAC 评分。与 GS 或 WA 单独治疗相比,DHJSD 联合 GS 或 WA 能更好地降低 VAS 和 WOMAC 评分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43af/9239816/e2441be2dbcd/BMRI2022-2350404.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验